June Sherie Almenoff - 15 Dec 2021 Form 4 Insider Report for BRAINSTORM CELL THERAPEUTICS INC. (BCLI)

Role
Director
Signature
/s/ June Sherie Almenoff
Issuer symbol
BCLI
Transactions as of
15 Dec 2021
Net transactions value
$0
Form type
4
Filing time
17 Dec 2021, 16:02:35 UTC
Previous filing
10 Dec 2021
Next filing
04 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCLI Common Stock Award $0 +2,000 +50% $0.000000 6,000 15 Dec 2021 Direct F1
holding BCLI Common Stock 7,175 15 Dec 2021 By Meadowlark Management LLC F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares acquired are shares of restricted stock awarded in connection with the Company's 2021 Annual Meeting of Stockholders pursuant to the Company's Second Amended and Restated Director Compensation Plan. The shares of restricted stock vest in 12 consecutive, equal monthly installments commencing on January 15, 2022 until fully vested on the first anniversary of December 15, 2021.
F2 The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for the purposes of Section 16 or for any other purpose.